Beilstein Journal of Organic Chemistry 2010, 6, No. 13.
relative to TMS. Absorption spectra and the melting tempera- performed using a modified protocol. Activator solution
tures (2.5 µM DNA, 250 mM NaCl, 10–90 °C, 0.7 °C/min, step (0.45 M tetrazole in acetonitrile) was pumped together with the
width 1.0 °C) were recorded on a Varian Cary 100 spectro- building block (0.15 M in acetonitrile) through the CPG vial.
meter equipped with a 6 × 6 cell changer unit. Fluorescence The coupling time was extended to 61 min with an intervening
spectra were acquired on a Jobin-Yvon Fluoromax 3 fluori- step after 30.8 min for washing and refreshing the activator/
meter in spectral steps of 1 nm and an integration time of 0.2 s. phosphoramidite solution in the CPG vial. The CPG vial was
All spectra were recorded with an excitation and emission band- flushed with dry acetonitrile after coupling. After preparation,
pass of 2 nm and are corrected for Raman emission from the the trityl-off oligonucleotides were cleaved from the resin and
buffer solution.
deprotected by treatment with concd. NH4OH at r.t. for 24 h.
Synthesis of 2. 2-Propyn-1-ol (40 µL, 700 µmol) was “Click” ligation. The azide 4 [18] (114 µL, 10 mM), Cu(I)
dissolved in DMF (5 mL). 1,1′-Carbonyldiimidazole (114 mg, (17 µL, 100 mM), TBTA (34 µL, 100 mM), each in DMSO :
700 µmol) was added and the solution was stirred at r.t. for 3 h. tBuOH = 3 : 1, and sodium ascorbate (25 µL, 400 mM) in H2O
3-(4,4′-Dimethoxytrityl)-2-hydroxypropylamine (1) (268 mg, were added to the oligonucleotide (1 µmol). The reaction mix-
700 µmol) was added and the solution was stirred for another ture was vortexed, shaken overnight at r.t. and then evaporated
24 h at r.t. and then evaporated to dryness. The crude product to dryness using a speedvac. Sodium acetate (100 µL,
was purified by flash chromatography (CH2Cl2, 0.1% NEt3) 0.15 mmol) was added and the mixture stored for 1 h at r.t.
yielding a yellow solid (44%). T.l.c. (CH2Cl2 : MeOH = 100 : Ethanol (1 mL) was added and the mixture vortexed and frozen
2) Rf = 0.3. 1H NMR (300 MHz, [d6]-acetone): δ = 7.51–7.48 (−20 °C) overnight. The suspension was centrifuged (13
ppm (m, 2H, arom. DMT), 7.37–7.28 (m, 7H, arom. DMT), 000 rpm, 15 min) and the supernatant removed. The pellet was
6.89–6.86 (m, 4H, arom. DMT), 6.26 (m, 1H, NH), 4.64 (d, J = washed twice with ethanol (500 µL, 70%) and then dissolved in
2.47, 2H, CH2CCH), 4.17 (d, J = 5.21, 1H, OH), 3.92–3.86 (m, water (500 µL). Prior to purification by HPLC the DNA was
1H, CH2CHCH2), 3.79 (s, 6H, OMe), 3.45–3.37 (m, 1H, desalted by NAP-5 column (GE Healthcare).
CH2CHCH2), 3.22–3.15 (m, 1H, CH2CHCH2), 3.13–3.05 (m,
2H, CH2CHCH2), 2.98 (t, J = 2.47, 1H, CCH). MS (FAB): m/z DNA purification. The modified oligonucleotides were puri-
(%) 303.1 (100) [DMT]+, 475,5 [MH+]. HRMS (FAB): M+ fied by HPLC on a semipreparative RP-C18 column (300 Å,
calc. for C28H30NO6 [MH+]: 476.2073; found: 476.2085.
Supelco) using the following conditions: A = NH4OAc buffer
(50 mM), pH = 6.5; B = acetonitrile; gradient 0–30% B over
Synthesis of 3. Compound 2 (350 mg, 0.74 mmol) was 50 min, flow rate 2.5 mL/min, UV–vis detection at 260 and
dissolved under argon in dry CH2Cl2 (5 mL). Dry ethyldiisop- 641 nm. The oligonucleotides were lyophilized and quantified
ropylamine (380 µL, 2.21 mmol) and 2-cyanoethyl-N,N-diisop- by their absorbance in water at 260 nm on a Varian Cary 100
ropylchlorophosphoramidite (181 µL, 0.81 mmol) were added. spectrometer. Duplexes were formed by heating to 90 °C
The solution was stirred for 3 h at r.t. Methanol (20 µL) was (15 min) followed by slow cooling. MS (ESI): DNA1: calc.
added to the mixture and stirred for 0.5 h to stop the reaction. 5455, found m/z = 1362.9 [M/4]4−, 1817.7 [M/3]3−; ε (260 nm)
The solution was evaporated to dryness and dissolved in dry = 159 090 [mol L−1 cm−1]; DNA2: calc. 5503, found m/z
MeCN (6.1 mL) and applied directly for automated DNA syn- =1375.1 [M/4]4−, 1833.8 [M/3]3−; ε (260 nm) = 164 290 [mol
thesis. T.l.c. (CH2Cl2 : MeOH = 100 : 2): Rf = 0.6. 1H NMR L−1 cm−1].
(300 MHz, [d6]-C3D6O): δ = 1.06–1.19 (m, 12H, 4*Me (iProp)),
2.58 (t, J = 6.04, 1H, ≡H), 2.76 (m, 2H), 2.95 (m, 1H), 3.07 (m, Acknowledgements
1H), 3.22 (m, 1H), 3.36 (m, 1H), 3.54 (m, 1H), 3.61 (m, 2H), This work was supported by the Deutsche Forschungsge-
3.85 (m, 1H), 3.75 (s, 6H, 2*OMe), 4.10 (m, 1H), 4.60 (dd, Jz = meinschaft (Wa 1386/9) and the University of Regensburg.
2.47, CH2≡), 6.20 (m, 1H, NH), 6.83–6.88 (m, 4H, arom.),
References
1. Wang, K.; Tang, Z.; Yang, C. J.; Kim, Y.; Fang, X.; Li, W.; Wu, Y.;
7.25–7.35 (m, 7H, arom.), 7.46–7.49 (m, 2H, arom.). 31P NMR
(121 MHz, [d6]-acetone): = 150.6.
Medley, C. D.; Cao, Z.; Li, J.; Colon, P.; Lin, H.; Tan, W.
Angew. Chem., Int. Ed. 2009, 48, 856–870.
Preparation of modified oligonucleotides. Oligonucleotides
were prepared on an Expedite 8909 synthesizer from Applied
2. Lavis, L. D.; Raines, R. T. ACS Chem. Biol. 2008, 3, 142–155.
Biosystems (ABI) using standard phosphoramidite chemistry.
Reagents and controlled pore glass (CPG) (1 µmol) were
purchased from Proligo. The synthesis of DNA oligonuc-
leotides modified with the acyclic linked acetylene was
3. Wagenknecht, H.-A. Ann. N. Y. Acad. Sci. 2008, 1130, 122–130.
Page 6 of 7
(page number not for citation purposes)